Medartis Holding AG / Key word(s): Personnel 24-Nov-2025 / 06:59 CET/CEST PRESS RELEASE Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.
Basel, 24 November 2025: Medartis Holding AG (MED:SW), a leading orthopaedic company specialising in head and extremity surgery, announces today that its Board has appointed Dr Peter Hackel as new Chief Financial Officer effective 1 January 2026. This leadership appointment is taking place at a crucial time for the company, as it capitalises on its recent acquisitions in arthroplasty (KeriMedical, Geneva) and value implants (NeoOrtho, Curitiba). |
Medartis appoints Peter Hackel as new Chief Financial Officer
Earlier from Medartis
- First TOUCH® CMC 1 Prosthesis Implanted in the United States
- Slide presentation of Medartis' half-year results 2025
- Publication of Medartis 2025 half-year results
- Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
- Medartis acquires remaining 53% stake in KeriMedical
Later from Medartis
- Medartis 2025 full year results presentation
- Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
- Press release 2025 full-year results
- Medartis shareholders endorse Board proposals with strong support at AGM 2026
- Medartis acquires CADskills, strengthening its position in patient-specific implants and titanium 3D printing
Follow Medartis into a list and get an email when it puts out news.
Follow Medartis